Home

Roy D. Baynes, Director: Travere Therapeutics TVTX Sell · Filed 06/16

Trade details

Type
Insider sale
Amount
$225,000
Shares · price
4,500 sh · $50.00 a share
Held after
41,500 sh
Trade date
26/06/12
Filed
26/06/16
Days to filing
4 days

Sold 9.8% of holdings

Share of holding sold
9.8%

Travere Therapeutics trades, last 26 weeks

What else happened in Travere Therapeutics around then

Filed or reported within 30 days of the trade day · 05/13~07/12

Roy D. Baynes's recent trades

  • Roy D. Baynes

    Planned sale10b5-1 planTravere Therapeutics

    $225K

    Filed 06/12

  • Roy D. Baynes

    Sell10b5-1 planTravere Therapeutics

    $209.9K

    Filed 05/06

  • Roy D. Baynes

    Planned sale10b5-1 planTravere Therapeutics

    $209.9K

    Filed 05/05

  • Roy D. Baynes

    Sell10b5-1 planTravere Therapeutics

    $431.1K

    Filed 05/04

  • Roy D. Baynes

    Planned sale10b5-1 planTravere Therapeutics

    $431.1K

    Filed 05/01